Clinical trial
Azithromycin/Bicillin Syphilis
NCT00031499 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00031499 |
|---|---|
| Title | Azithromycin/Bicillin Syphilis |
| Official title | A Phase III Equivalence Trial of Azithromycin vs. Benzathine Penicillin for the Treatment of Early Syphilis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Syphilis |
| Intervention type | Drug |
| Interventions | Azithromycin, Benzathine Penicillin, Doxycycline |
| Enrollment | 593 |
| Start date | Jun 1, 2000 |
| Primary completion | Aug 1, 2007 |
| Completion | Mar 1, 2009 |
| First posted | Mar 7, 2002 |
| Last update posted | Apr 29, 2013 |
| Countries | Madagascar, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: